Seattle makes waves in e-cardiology tech
Seattle-headquartered company Bardy Diagnostics has impressed Europe’s cardiology congresses with its e-cardiology technology, winning the Remote Monitoring in Arrhythmias Digital Health Pitch Session at the European Society of Cardiology (ESC) Congress 2019.
Bardy Diagnostics, Inc (BardyDx), an innovator in digital health and remote patient monitoring, won the pitch with its Carnation Ambulatory Monitor (CAM™), the only P-wave centric ambulatory cardiac patch monitoring and arrhythmia detection device. The hourglass-shaped CAM patch is placed on the centre of the chest, directly over the heart for optimum ECG detection and clear recording of the often difficult-to-detect P-wave, the signal of the ECG waveform that is essential for accurate arrhythmia diagnosis.
In addition, BardyDx Founder and Chief Executive Officer, Gust H. Bardy, MD was invited to speak at Heart Rhythm Congress (HRC) 2019 held at The International Convention Centre in Birmingham, UK in October, speaking on “The importance of P-Wave centric ECG monitoring analysis”.
BardyDx is at the heart of Seattle’s pioneering medical research and health care community, which is leading innovation in areas from heath tech to cancer research.
Dr. Bardy is a leading figure in Seattle’s cardiac research core, holding a faculty position as Clinical Professor of Medicine, Cardiology at the University of Washington. He is also the Director of the Seattle Institute for Cardiac Research. He has developed technological solutions to patient rhythm problems with over 240 U.S. patents issued, most of which have been incorporated in cardiac rhythm management technologies in use by many medical device companies. His previous company, Cameron Health, was acquired by Boston Scientific in 2012 for its revolutionary Subcutaneous Implantable Defibrillator (S-ICD) product.
The ESC is the largest gathering of leaders in cardiovascular medicine in the world, with over 500 sessions and an estimated 30,000 delegates. The pitch event was held as part of ESC’s focus on highlighting innovative technological applications in the field of e-cardiology, including wearable devices, mobile apps, electronic health records, remote monitoring and big data.
Ken Nelson, BardyDx Chief Commercial Officer and pitch session presenter, said: “It is an honor for the CAM patch to be chosen and recognized as one of the best remote cardiac monitoring solutions from among those presenting by an audience of pioneering cardiac physicians and industry thought leaders.”
The growing market recognition of the CAM patch includes recently being named finalists for the UCSF Digital Health Awards for Best Cardiovascular Digital Diagnostic and the Medtech Insight Awards for Best Technological Diagnostic Innovation & Best Proof-of-Value of an Innovation. Earlier this year, BardyDx was also named the winner of the 2019 MedTech Breakthrough Award for Best New Diagnostic Technology and the winner of the 2019 Frost & Sullivan Award for Technology Innovation in Remote Cardiac Monitoring.
Published Date: 30/10/2019